New York, NY–(BUSINESS WIRE)–The American Neurological Association (ANSA) today announced a $250,000 grant to help advance a new research initiative that will provide a more comprehensive look at the pathophysiology of dementia.
ANSA President and CEO John R. Agranoff announced the new grant to the National Institutes of Health in an interview with National Public Radio.
“This is a great example of how the research community is looking at the brain,” Agranon said.
“The ANSA’s vision is to get to the heart of dementia research, which is how we identify and understand the underlying mechanisms of disease, the underlying molecular mechanisms of pathology and how to intervene to slow or reverse the course of disease.”
The Alzheimer’s Association (AIA) is also participating in the new effort.
“There’s been a lot of talk in the neuroscientific community about the relationship between Alzheimer’s and brain function,” said John L. Oates, M.D., director of neurosurgery at the National Alzheimer’s Research Center in Bethesda, Maryland.
“What the Alzheimer’s community needs to know is that dementia is a disease, and there is no one-size-fits-all model for dementia.
The Alzheimer Association is really working to bring people together and make this an inclusive effort.”
The Alzheimer’s Society and the American Academy of Neurology (AAN) are also participating.
The American Neurology Association’s Institute of Neurological and Orthopaedic Sciences is the lead research institute.
The National Institutes at NIH is responsible for coordinating the research effort.
The ANSA is a national association of the medical sciences, with more than 5,000 members and affiliates in more than 120 countries.
More information on the ANSA and its initiatives can be found at www.ansa.org.
For more information on Alzheimer’s disease, visit www.nccap.gov.